Profile cover photo
Profile photo
Shezad Malik
Personal Injury Attorney, Dangerous Drugs and Defective Medical Devices
Personal Injury Attorney, Dangerous Drugs and Defective Medical Devices

Shezad Malik's posts

Post has attachment
Invokana Diabetic Ketoacidosis Injury

Invokana Diabetic Ketoacidosis Injury. Invokana linked to kidney failure, leg amputations, and diabetic ketoacidosis according to lawsuits.

What is Invokana?

Invokana (canagliflozin) is a new type 2 diabetic medication released in March 2013 and has been touted by Janssen Pharmaceuticals and Johnson & Johnson as being superior to the older types of diabetic medications.

Post has attachment
Actemra Serious Heart and Lung Injuries

Actemra patients were more likely to have a lung disease event than patients taking Remicade and just as likely as those using Humira.

Actemra patients were 1.5 times more likely to experience a heart attack or stroke as those using Enbrel.

Actemra Injury Lawsuit Allegations

According to allegations in Actemra lawsuits against Roche, the drug maker placed their desire for profits before patient safety by withholding important warnings about the risk of heart attacks, strokes, heart failure, lung disease, pancreatitis and other harmful side effects.

Post has attachment
Injured diabetic patients have filed Invokana product liability and personal injury lawsuits against Janssen Pharmaceuticals and it’s parent company, Johnson & Johnson, claiming that the drug makers failed to adequately research the medication or warn patients and doctors about the potential health risks with Invokana.

Invokana Amputation Injuries

Invokana linked to kidney failure, urinary tract infections, leg amputations and diabetic ketoacidosis according to lawsuits.

Post has attachment
Invokana doubles Amputation risk according to studies

Based on new data from two large clinical trials, the FDA in May 2017 concluded that the type 2 diabetes medicines Invokana, Invokamet, Invokamet XR caused an increased risk of leg and foot amputations.

The FDA is requiring new warnings, including their most prominent Boxed Warning, to be added to the Invokana drug labels to describe this risk.

Post has attachment
Roundup Lawsuits

All federal Roundup lawsuits have been centralized and consolidated as part of an MDL or multidistrict litigation, before U.S. District Judge Vince Chhabria in the Northern District of California.

As of June 15, a hundred federal product liability and personal injury lawsuits have been filed by workers who say they were diagnosed with non-Hodgkin’s lymphoma cancer after spraying Roundup. There are more than 1,100 plaintiffs with pending lawsuits in state and federal courts throughout the U.S.

The lymphoma cancer-stricken workers claim that Monsanto failed to provide adequate warnings that long-term use of the glyphosate-based weed killer could substantially increase the risk of non-Hodgkin’s lymphoma and other deadly cancers.

Post has attachment
According to lawsuits, Smith & Nephew has received hundreds of adverse reports and premature hip implant failure complaints regarding the BHR but did not report to the FDA promptly. Smith & Nephew was aware of the stark and obvious evidence that the BHR systems were wearing down quicker and more severely than anticipated. Despite this knowledge, Smith & Nephew failed to take corrective action to address the failure problems.

Post has attachment
Many FDA Invokana Warnings

Invokana was released in March 2013, and the drug makers have aggressively marketed the drug in an attempt to convince doctors to switch their patients to the medication.

Over the past few years, the FDA has required a number of Invokana warning updates, as new safety risks have been linked to the medication.

Post has attachment
Invokana linked to serious side effects. According to many medical experts, Invokana medication is linked to severe and life-threatening side effects including kidney failure, leg amputations, heart attacks and diabetic ketoacidosis.

Post has attachment
What is Ethicon Physiomesh?

Ethicon Physiomesh has a sandwich design, with two layers of polyglecaprone-25, and two layers of polydioxanone film. The coating was applied to the polypropylene mesh to reduce adhesion, inflammation and help the mesh fix into the body.

According to Guerra's complaint “The multi-layer coating of Defendants’ Physiomesh is cytotoxic, immunogenic, and not biocompatible, which causes or contributes to complications such as delayed wound healing, inflammation, foreign body response, rejection, infection, and other complications.”

Post has attachment
Decision leads to mistrial in Talcum Powder Ovarian Cancer Trial

After the Supreme Court ruling, St. Louis Circuit Judge Burlison declared a mistrial in a Missouri state court case in which three plaintiffs, two from out-of-state, had filed against Johnson & Johnson, over its talcum powder allegedly ovarian cancer.

Missouri, California and several other states have allowed non-resident plaintiffs to file claims in their state court system. According to these states if a company does business in their state, it is enough of a connection to allow a plaintiff to file a complaint in that state, irrespective of where that plaintiff is from or where the company is located.
Wait while more posts are being loaded